CIK 0000096943
- Large accelerated filer
TELEFLEX INC
Sign in to watch- Ticker
- TFX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 231147939
- Phone
- +1 610-225-6800
- Business address
- 550 E SWEDESFORD RD, SUITE 400, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-25 | Deren John VP & Chief Accounting Officer | Grant or award | +222 | 2,233 | ||
| 2020-02-25 | Deren John VP & Chief Accounting Officer | Grant or award · Stock Option / (Right to Buy) | +2,167 | 2,167 | ||
| 2020-02-25 | Leyden James J VP, General Counsel, Secretary | Grant or award | +614 | 14,141 | ||
| 2020-02-25 | Leyden James J VP, General Counsel, Secretary | Grant or award · Stock Option / (Right to Buy) | +5,996 | 5,996 | ||
| 2020-02-25 | Hicks Cameron P Vice President, Global HR | Grant or award | +410 | 7,516.02 | ||
| 2020-02-25 | Hicks Cameron P Vice President, Global HR | Grant or award · Stock Option / (Right to Buy) | +3,997 | 3,997 | ||
| 2020-02-25 | Wijker Mario Vice President, QARA | Grant or award | +199 | 582 | ||
| 2020-02-25 | Wijker Mario Vice President, QARA | Grant or award · Stock Option / (Right to Buy) | +1,940 | 1,940 | ||
| 2020-02-25 | Kelly Liam President & CEO | Grant or award | +3,215 | 24,386.1 | ||
| 2020-02-25 | Kelly Liam President & CEO | Grant or award · Stock Option / (Right to Buy) | +31,371 | 31,371 | ||
| 2020-02-25 | Winters James Vice President, Mfg and Supply | Grant or award | +331 | 963 | ||
| 2020-02-25 | Winters James Vice President, Mfg and Supply | Grant or award · Stock Option / (Right to Buy) | +3,234 | 3,234 | ||
| 2020-02-25 | POWELL THOMAS E Executive Vice President & CFO | Grant or award | +1,331 | 12,028 | ||
| 2020-02-25 | POWELL THOMAS E Executive Vice President & CFO | Grant or award · Stock Option / (Right to Buy) | +12,992 | 12,992 | ||
| 2020-02-25 | Klasko Stephen K. M.D. Director | Exercise or conversion | +200 | $58.25 | $12K | 937.94 |
| 2020-02-25 | Klasko Stephen K. M.D. Director | Sale | −200 | $360.95 | $72K | 737.94 |
| 2020-02-25 | Klasko Stephen K. M.D. Director | Exercise or conversion · Stock Option / (Right to Buy) | −200 | 1,600 | ||
| 2020-02-18 | SMITH BENSON Director | Shares withheld for taxes | −1,106 | $376.44 | $416K | 47,860.64 |
| 2020-01-27 | Klasko Stephen K. M.D. Director | Exercise or conversion | +200 | $58.25 | $12K | 936 |
| 2020-01-27 | Klasko Stephen K. M.D. Director | Sale | −200 | $375.71 | $75K | 736 |
Page 25 of 45 · 899 trades